Retinal vascular perfusion density mapping using optical coherence tomography angiography in normals and diabetic retinopathy patients

Retina

Volumn 35, Issue 11, 2015, Pages 2353-2363

  Agemy, Steven A ^a,b   Scripsema, Nicole K ^a   Shah, Chirag M ^c   Chui, Toco ^a,b   Garcia, Patricia M ^a,b   Lee, Jessica G ^a,b   Gentile, Ronald C ^a,b,d   Hsiao, Yi Sing ^e   Zhou, Qienyuan ^e   Ko, Tony ^e   Rosen, Richard B ^a,b  

^a NEW YORK EYE AND EAR INFIRMARY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d WINTHROP UNIVERSITY HOSPITAL   (United States)

^e Optovue Inc   (United States)

Author keywords

Diabetic retinopathy; Imaging; Optical coherence tomography angiography

Indexed keywords

ADULT; ARTICLE; CHOROID CAPILLARY LAYER; CLINICAL FEATURE; CONTROLLED STUDY; DIABETIC RETINOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT REPEATABILITY; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY; REPRODUCIBILITY; RETINA CAPILLARY; RETINAL VASCULAR PERFUSION DENSITY MAPPING; RETROSPECTIVE STUDY; SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY; VISUAL SYSTEM EXAMINATION; AGED; BLOOD FLOW; BLOOD FLOW VELOCITY; CAPILLARY; CHOROID; COMPARATIVE STUDY; FLUORESCENCE ANGIOGRAPHY; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RETINA; RETINA BLOOD VESSEL; VISUAL ACUITY;

ADULT; AGED; BLOOD FLOW VELOCITY; CAPILLARIES; CHOROID; DIABETIC RETINOPATHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MALE; MIDDLE AGED; REGIONAL BLOOD FLOW; REPRODUCIBILITY OF RESULTS; RETINA; RETINAL VESSELS; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84946022497     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0000000000000862     Document Type: Article

References (32)

1. Klein R, Klein BE, Moss SE, et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984;102:527-532.
2. Liteh Wu, Fernandez-Loaiza P, Sauma J, et al. Classification of diabetic retinopathy and diabetic macular edema. World J Diabetes 2013;4:290-294.
3. Saaddine JB, Honeycutt AA, Narayan KM, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol 2008;126:1740-1747.
4. Ferris FL. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1291.
5. Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Invest Ophthalmol Vis Sci 1981;21:1-226.
6. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early treatment diabetic retinopathy study research group. Ophthalmology 1991;98:786-806.
7. Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2013;110:1677-1682.
8. Gass JD. A fluorescein angiographic study of macular dysfunction secondary to retinal vascular disease. IV. Diabetic retinal angiopathy. Arch Ophthalmol 1968;80:583-591.
9. Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early treatment diabetic retinopathy study research group. Ophthalmology 1991;98:807-822.
10. Conrath J, Giorgi R, Raccah D, Ridings B. Foveal avascular zone in diabetic retinopathy: quantitative vs qualitative assessment. Eye 2005;19:22-326.
11. Yannuzzi LA, Rohrer KT, Tindel LJ, et al. Fluorescein angiography complication survey. Ophthalmology 1986;93:611-617.
12. Karhunen U, Raitta C, Kala R. Adverse reactions to fluorescein angiography. Acta Ophthalmol 1986;64:282-286.
13. Kwiterovitch KA, Maguire MG, Murphy RP, et al. Frequency of adverse systemic reactions occurring after fluorescein angiography - results of a prospective study. Ophthalmology 1991;98:1139-1142.
14. Yeung L, Lima VC, Garcia P, et al. Correlation between spectral domain optical coherence tomography findings and fluorescein angiography patterns in diabetic macular edema. Ophthalmology 2009;116:1158-1167.
15. Yali J, Ou T, Tokayer J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012;20:4710-4725.
16. Jia Y, Bailey S, Hwang T, et al. Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc Natl Acad Sci USA Proceedings of the National Academy of Sciences 2015.
17. Ishibazawa A, Nagaoka T, Takahashi A, et al. Optical coherence tomography angiography in diabetic retinopathy: a prospective Pilot study. Am J Ophthalmol 2015;160:35-44.
18. American National Standard for Safe Use of Lasers. ANSI Z136.1e2007. Orlando, FL: Laser Institute of America; 2007.
19. Jia Y, Bailey ST, Wilson DJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 2014; 121:1435-1444.
20. Jia Y, Wei E, Wang X, et al. Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology 2014;121:1322-1332.
21. Spaide RF, Klancnik JM Jr., Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 2015;133: 45-50.
22. Pechauer AD, Jia Y, Liu L, et al. Optical coherence tomography angiography of peripapillary retinal blood flow response to hyperoxia. Invest Ophthalmol Vis Sci 2015;56:3287-3291.
23. Kraus MF, Potsaid B, Mayer MA, et al. Motion correction in optical coherence tomography volumes on a per A-scan basis using orthogonal scan patterns. Biomed Opt Express 2012;3: 1182-1199.
24. Lin SC, Singh K, Jampel HD, et al. Ophthalmic Technology Assessment:Optic nerve Head and retinal nerve fiber analysis. A report by the american Academy of Ophthalmology, Ophthalmology 2007;114:1937-1949.
25. Mwanza JC, Oakley JD, Budenz DL, Anderson DR. Ability of cirrus HD-OCT optic nerve head parameters to discriminate normal from glaucomatous eyes. Ophthalmology 2011;118: 241-248.
26. Leung CK, Yu M, Weinreb RN, et al. Retinal nerve fiber layer imaging with spectral-domain optical coherence tomography: patterns of retinal nerve fiber layer progression. Ophthalmology 2012;119:1858-1866.
27. Bresnick GH, Condit R, Syrjala S, et al. Abnormalities of the foveal avascular zone in diabetic retinopathy. Arch Ophthalmol 1984;102:1286-1293.
28. Yu S, Pang CE, Gont Y, et al. The spectrum of superficial and deep capillary ischemia in retinal artery occlusion. Am J Ophthalmol 2015;159:53-63.
29. Yu DY, Cringle SJ, Alder V, Su EN. Intraretinal oxygen distribution in the rat with graded systemic hyperoxia and hypercapnia. Invest Ophthalmol Vis Sci 1999;40:2028-2087.
30. Querques G, Lattanzio R, Querques L, et al. Enhanced depth imaging optical coherence tomography in type 2 diabetes. Invest Ophthalmol Vis Sci 2012;53:6017-6024.
31. Niki T, Muraoka K, Shimizu K. Distribution of capillary nonperfusion in early-stage diabetic retinopathy. Ophthalmology 1984;91:1431-1439.
32. De Carlo TE, Salz DA, Waheed NK, et al. Visualization of the retinal vasculature using wide-field montage optical coherence tomography angiography. Ophthalmic Surg Lasers Imaging Retina 2015;46:611-616.